XML 97 R81.htm IDEA: XBRL DOCUMENT v3.10.0.1
NONCONSOLIDATED AFFILIATES (Impact of Sales to Nonconsolidated Affiliates) (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Schedule of Equity Method Investments [Line Items]      
Equity method investments $ 3,823 $ 3,742  
Other noncurrent obligations (495) (752)  
Equity Method Investment, Net of Investment Liabilities $ 3,328 $ 2,990  
Customer Concentration Risk | Equity Method Investee | MEGlobal      
Schedule of Equity Method Investments [Line Items]      
Concentration Risk, Percentage 1.00% 1.00% 1.00%
Customer Concentration Risk | Equity Method Investee | HSC Group      
Schedule of Equity Method Investments [Line Items]      
Concentration Risk, Percentage 1.00% 1.00%  
Sadara Chemical Company | Equity Method Investee | Sadara Chemical Company      
Schedule of Equity Method Investments [Line Items]      
Concentration Risk, Percentage 8.00% 3.00%  
SCG-Dow Group | Equity Method Investee | SCG-Dow Group      
Schedule of Equity Method Investments [Line Items]      
Concentration Risk, Percentage   2.00% 3.00%
SCG-Dow Group | Supplier Concentration Risk | Equity Method Investee | SCG-Dow Group      
Schedule of Equity Method Investments [Line Items]      
Concentration Risk, Percentage 2.00%